Large Language Model Influence on Diagnostic Reasoning
Ethan Goh, Robert Gallo, Jason Hom et al. · JAMA Network Open · 2024 · Randomised trial
Full textCC BY
All papers
Filters2 filters applied
Topic
- Health Sciences
- Life Sciences
- Social Sciences
- Physical Sciences
- Topic not added yet1,268
Status
- Expression of concern
- Corrected
- No notice
- From publisher notices and Retraction Watch. Not checked means nobody has looked yet.
Year
Readable here
Study type
Licence
1,527 papers1 Expression of concern95 Corrected
Amyloid and Tau Prediction of Cognitive and Functional Decline in Unimpaired Older Individuals: Longitudinal Data from the A4 and LEARN Studies
Reisa A. Sperling, M.C. Donohue, R.A. Rissman et al. · The Journal of Prevention of Alzheimer's Disease · 2024 · Randomised trial
Full textCC BY
Neoadjuvant chemotherapy with or without camrelizumab in resectable esophageal squamous cell carcinoma: the randomized phase 3 ESCORT-NEO/NCCES01 trial
Jianjun Qin, Liyan Xue, Anlin Hao et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
Resistant starch intake facilitates weight loss in humans by reshaping the gut microbiota
Huating Li, Lei Zhang, Jun Li et al. · Nature Metabolism · 2024 · Randomised trial
Full textCC BY
Effects of tirzepatide on circulatory overload and end-organ damage in heart failure with preserved ejection fraction and obesity: a secondary analysis of the SUMMIT trial
Barry A. Borlaug, Michael R. Zile, Christopher M. Kramer et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial
Johannes F. E. Mann, Peter Rossing, George Bakris et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
Arun J. Sanyal, Lee M. Kaplan, Juan P. Frias et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
Donna H. Ryan, Ildiko Lingvay, John Deanfield et al. · Nature Medicine · 2024 · Randomised trial
Full textCC BY
A small-molecule TNIK inhibitor targets fibrosis in preclinical and clinical models
Feng Ren, Alex Aliper, Jian Chen et al. · Nature Biotechnology · 2024 · Randomised trial
Full textCC BY
Blinded, randomized trial of sonographer versus AI cardiac function assessment
Bryan He, Alan C. Kwan, Jae Hyung Cho et al. · Nature · 2023 · Randomised trial
Full textCC BY
Asciminib vs bosutinib in chronic-phase chronic myeloid leukemia previously treated with at least two tyrosine kinase inhibitors: longer-term follow-up of ASCEMBL
Andreas Hochhaus, Delphine Réa, Carla Boquimpani et al. · Leukemia · 2023 · Randomised trial
Full textCC BY
Natriuresis-guided diuretic therapy in acute heart failure: a pragmatic randomized trial
Jozine M. ter Maaten, Iris E. Beldhuis, Peter van der Meer et al. · Nature Medicine · 2023 · Randomised trial
Full textCC BY
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results
Valsamo Anagnostou, Cheryl Ho, Garth Nicholas et al. · Nature Medicine · 2023 · Randomised trial
Full textCC BY
Effectiveness of Lumbar Cerebrospinal Fluid Drain Among Patients With Aneurysmal Subarachnoid Hemorrhage
Stefan Wolf, Dorothee Mielke, Christoph Barner et al. · JAMA Neurology · 2023 · Randomised trial
Full textCC BY
Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial
Robert S. Rosenson, Daniel Gaudet, Christie M. Ballantyne et al. · Nature Medicine · 2023 · Randomised trial
Full textCC BY
Estimation of cell lineages in tumors from spatial transcriptomics data
Beibei Ru, Jinlin Huang, Yu Zhang et al. · Nature Communications · 2023 · Randomised trial
Full textCC BY
Trofinetide for the treatment of Rett syndrome: a randomized phase 3 study
Jeffrey L. Neul, Alan K. Percy, Timothy A. Benke et al. · Nature Medicine · 2023 · Randomised trial
Full textCC BY
Corrected Adjuvant nivolumab in resected stage IIB/C melanoma: primary results from the randomized, phase 3 CheckMate 76K trial
John M. Kirkwood, Michele Del Vecchio, Jeffrey Weber et al. · Nature Medicine · 2023 · Randomised trial
Full textCC BY
A Placebo-Controlled Trial of Percutaneous Coronary Intervention for Stable Angina
Christopher A. Rajkumar, Michael J. Foley, Fiyyaz Ahmed-Jushuf et al. · New England Journal of Medicine · 2023 · Randomised trial
Full textCC BY
Resmetirom for nonalcoholic fatty liver disease: a randomized, double-blind, placebo-controlled phase 3 trial
Stephen A. Harrison, Rebecca Taub, Guy W. Neff et al. · Nature Medicine · 2023 · Randomised trial
Full textCC BY